Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone (Q43422461)
Jump to navigation
Jump to search
scientific article published in February 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone |
scientific article published in February 2002 |
Statements
1 reference
Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone (English)
1 reference
Andreas H Sarris
1 reference
Yunfang Jiang
1 reference
Athanasios Thomaides
1 reference
George Z Rassidakis
1 reference
Richard J Ford
1 reference
L Jeffrey Medeiros
1 reference
Fernando Cabanillas
1 reference
Peter McLaughlin
1 reference
1 February 2002
1 reference
1 reference
29
1 reference
1 Suppl 2
1 reference
48-55
1 reference
Identifiers
1 reference
1 reference